Riot Acquires 13% Stake in Bitfarms, CEO Opposes 'Poison Pill' Strategy
Riot Platforms has acquired a 13.1% stake in Bitfarms, with plans for further acquisitions, but Bitfarms prevents it from exceeding a 15% stake through a "poison pill" strategy that Riot CEO Jason Les accuses of violating legal standards. Riot disclosed on June 11 that it had purchased about 6 million shares of Bitfarms stock for $111 million, and Bitfarms shares rose more than 56 percent after the news of the acquisition. former Bitfarms CEO Geoffrey Morphy resigned, and Nicolas Bonta stepped in as president.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
